33.39 USD
▼-0.68-2.00%
盘后 32.93 -1.38%
2026-11-19
市值
$2.14B
市盈率
3.35
EPS
9.93
股息率
—
52 周区间
25.68 – 36.24
成交量
293.30K
Beta
0.01
目标价
30.78
52W 低 25.6852W 高 36.24
价格走势
公司简介
Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company’s pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in a phase 1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relaps...